Skip to content

Omega-3 review finds no clear improvement in walking with peripheral artery disease

Compared with placebo, the studied supplements showed no detected change in walking distances or vascular measures. The findings leave uncertainty about particular formulations.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The review found no improvement in pain-free or maximal walking distance with the studied supplements compared with placebo. Vascular measures, inflammatory markers, cholesterol and blood pressure also showed no reported change. These results do not support a clear benefit in this population, but the evidence was insufficient to rule out effects of particular formulations.

Keep in mind

The abstract reports neither pooled effect estimates nor confidence intervals and gives no assessment durations. That makes it difficult to judge how precisely the findings exclude potentially useful effects.

THE RESULT, WITH CONTEXT

What researchers found

No reported improvement

Pain-free and maximal walking distance

EPA alone or EPA plus DHA versus placebo across included studies; assessment durations were not reported in the abstract.

Nutr Metab Cardiovasc Dis, 2026 · Original source ↓

Function and vascular measures

Walking distance was a primary functional outcome, alongside ankle-brachial index and flow-mediated vasodilation. The absence of reported improvement extended to both pain-free walking and the maximum distance participants could walk.

Formulation questions remain

The authors leave open whether particular formulations could help selected groups. Their call for more research is an expression of uncertainty, rather than evidence that a different formulation or higher dose is effective.

CHECK THE ORIGINAL

The original publication

The effectiveness of intervention with omega-3 fatty acids, eicosapentaenoic and docosahexenoic acid in peripheral arterial disease: a systematic review and meta-analysis.

Dao TK, Nerlekar N, Nicholls SJ et al.
Nutr Metab Cardiovasc Dis · 2026

PubMed ID
40940198
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.